-
A Controlled Trial of Rivaroxaban After Transcatheter Aortic-Valve ReplacementGD Dangas, JGP Tijssen, the GALILEO Investigators et al. -
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Bicuspid Aortic Valve StenosisR Waksman, PE Craig, R Torguson et al.
-
Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk PatientsDKolte, GJ Vlahakes, IF Palacios et al.
-
5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical TrialMohamed Abdel-Wahab, M Landt, Franz-Josef Neumann
-
5-Year Outcomes Comparing Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney DiseaseS Garcia, RJ Cubeddu, RT Hahn et al.
-
Ascending Aortic Length and Risk of Aortic Adverse Events: The Neglected DimensionJ Wu, MA Zafar, Yupeng Li, JA Elefteriades et al.
-
2020 ACC Expert Consensus Decision Pathway on Management of Conduction Disturbances in Patients Undergoing Transcatheter Aortic Valve Replacement A Report of the American College of Cardiology Solution Set Oversight CommitteeWriting Committee, SM Lilly, AJ Deshmukh et al.
-
Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and RegistriesH Gonzales, PS Douglas, BR Lindman et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
